BioInformant.com is the first and only market research firm to specialize in the stem cell industry. BioInformant research has been cited by the Wall Street Journal, Xconomy, and Vogue Magazine. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.

Page

Global Cord Blood Banking Industry Report 2021

By BioInformant Worldwide, L.L.C. | Healthcare | Feb 2021 | Page 232

Global Cord Blood Banking Industry Report 2021....

USD 3997 View Report

Mesenchymal Stem Cells - Advances and Applications, 2021

By BioInformant Worldwide, L.L.C. | Healthcare | Feb 2021 | Page 276

Mesenchymal Stem Cells - Advances and Applications, 2021 market research report available in single user pdf license with Aarkstore Enterprise at USD 5500....

USD 5500 View Report

Stem Cell Research Products - Opportunities, Tools, & Technologies

By BioInformant Worldwide, L.L.C. | Biotechnology | Oct 2020 | Page 175

Stem Cell Research Products - Opportunities, Tools, & Technologies....

USD 3797 View Report

Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends

By BioInformant Worldwide, L.L.C. | Healthcare | Feb 2019 | Page 195

CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer. ....

USD 3795 View Report

The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, and Distribution

By BioInformant Worldwide, L.L.C. | Pharmaceuticals and Healthcare | Jul 2017 | Page 123

The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, and Distribution    Traditionally, one of the major issues with commercializing cell therapy products has been manufacturing....

USD 2495 View Report